Sartorius Stedim Biotech SA Stock Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
08:27am | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
Sales 2024 * | 2.96B 3.15B | Sales 2025 * | 3.37B 3.59B | Capitalization | 19.12B 20.36B |
---|---|---|---|---|---|
Net income 2024 * | 343M 365M | Net income 2025 * | 459M 489M | EV / Sales 2024 * | 7.32 x |
Net Debt 2024 * | 2.5B 2.66B | Net Debt 2025 * | 2.29B 2.44B | EV / Sales 2025 * | 6.35 x |
P/E ratio 2024 * |
54.1
x | P/E ratio 2025 * |
38.9
x | Employees | - |
Yield 2024 * |
0.45% | Yield 2025 * |
0.57% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
-2.73% | 186B | |
-2.20% | 107B | |
-4.08% | 67.57B | |
+5.99% | 50.7B | |
+15.32% | 47.2B | |
-0.45% | 39.72B | |
+6.60% | 27.48B | |
-1.11% | 25.65B | |
-0.76% | 24.82B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock